What You Should Know:
- President Biden’s administration today announced a historic manufacturing deal between Merck and Johnson & Johnson (J&J), to expand production of J&J’s COVID-19 vaccine. The collaboration will increase manufacture of vaccine drug substance, as well as its fill-finish capacity – two of the biggest bottlenecks facing J&J in the production of its vaccine.
- In addition, the U.S. Department of Health and Human Services (HHS) will collaborate with Merck
Read More
Health Gorilla Nabs $15M to Expand FHIR-based APIs for Digital Health
What You Should Know:
- Health Gorilla raises $15M to scale its FHIR-based API solutions for digital health and expand into new markets.
- Health Gorilla will introduce new APIs to enable consumer access to medical records, payer-to-payer data sharing, and data quality assessments.
Health Gorilla, a Sunnyvale, CA-based provider of healthcare APIs, today announced it has raised $15 million in Series B financing co-led by IA Capital and Nationwide, with participation
Read More
Highmark Health Taps Verily to Build Digital Health Tools for Living Health Model
What You Should Know:
- Highmark Health has engaged Verily to build out digital health tools for patients and analytics solutions for Highmark’s clinicians as part of its Living Health model. This marks the first collaboration of its kind for Verily, Google Cloud and a partner.
- Highmark Health is a Blue Cross Blue Shield health plan based in Western PA with 4.5 million members and an integrated delivery system (Allegheny) with 9
Read More
ObvioHealth, RedHill Biopharma Launches First in Kind Remote COVID-19 Therapy Trial
What You Should Know:
- RedHill Biopharma, a specialty biopharmaceutical company, and ObvioHealth, a global virtual research organization, have partnered on the largest remote clinical study for a new at-home COVID-19 treatment, Upamostat.
- The trial is being performed completely remotely in patients’ homes using ObvioHealth’s clinical trial ecosystem including digital devices, a patient-centric smartphone application and home healthcare visits.
- The randomized, double-blind,
Read More
Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds
What You Should Know:
Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III.
The three new funds include a broad range of medical institutions, university endowments, foundations, pension funds and sovereign wealth funds.
- OrbiMed Private Investments
Read More
Innovaccer Reaches $1.3B Valuation, Launches Health Cloud Platform
What You Should Know:
- Innovaccer closes Series D round of growth capital bringing Innovaccer at a total valuation of $1.3 billion.
- In addition, the company has launched the Innovaccer Health Cloud, a platform as a service that combines the company’s Data Activation Platform and application suite with an extensive set of platform services and tools that allow customers and partners to easily develop interoperable applications that improve patient outcomes and lower
Read More
Emory Healthcare Taps Rimidi to Create FHIR-Based Apps for Orthopedic Surgery and Deep Brain Stimulation
What You Should Know:
- Rimidi, a cloud-based software platform that enables personalized management of health conditions across populations, today announced a strategic collaboration with Emory Healthcare to develop new patient and provider-facing FHIR apps.
- Specifically, the apps will create a more collaborative and transparent experience for patients undergoing orthopedic surgery, as well as for those referred to the deep brain stimulation (DBS) program for Parkinson’s and other
Read More
Microsoft, UCB Launch Collaboration to Accelerate Drug Discovery and Development
What You Should Know:
- Global biopharma company UCB and Microsoft announced today a new, multi-year strategic collaboration to advance UCB’s digital transformation, change the way care is delivered, and accelerate better outcomes for people living with severe diseases.
- The partnership builds on the companies’ joint work as part of the COVID Moonshot project which sought to create an orally bioavailable anti-viral for COVID-19. During the project, UCB completed six
Read More
DrChrono’s Open FHIR API Enables Patients to Transfer Records to Apple Health
What You Should Know:
- DrChrono announces today that its open FHIR API is now live enabling its patient members to securely transfer their available health records out of DrChrono into the Apple Health app on the iPhone so their medical information is consolidated and always with them.
- The Health Records feature is part of the Health app, which also shows activity, heart rate, nutrition and other health data consolidated from iPhone, Apple Watch and HealthKit-enabled third-party
Read More
CVS Launches Community-Based Strategy to Address COVID-19 Vaccine Education and Equity
What Should Know:
- CVS Health unveils community-based strategy increase access to COVID-19 vaccinations for vulnerable communities and advance vaccine education while combating hesitancy.
- The strategy includes a strategic partnership with Lyft to help underserved communities access vaccination appointments by providing free or discounted rides for those in need.
CVS Health unveils its community-based strategy to address potential inequities related to COVID-19 vaccine access in
Read More
